ANGEL MARIA
CARRACEDO ALVAREZ
Catedrático de universidade
Hospital Universitario de Salamanca
Salamanca, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Salamanca (13)
2024
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2019
-
Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected Patient
Clinical Drug Investigation, Vol. 39, Núm. 11, pp. 1125-1131
2016
-
Gene–gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients
Drug Metabolism and Pharmacokinetics, Vol. 31, Núm. 5, pp. 349-355
-
High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma
Annals of Hematology, Vol. 95, Núm. 2, pp. 253-262
-
Natural resistance to Meningococcal Disease related to CFH loci: Meta-analysis of genome-wide association studies
Scientific Reports, Vol. 6
2015
-
Association between SNPs of metalloproteinases and prostaglandin f2α receptor genes and latanoprost response in open-angle glaucoma
Ophthalmology, Vol. 122, Núm. 5, pp. 1040-1048.e4
2014
-
Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients
Personalized Medicine, Vol. 11, Núm. 7, pp. 693-704
-
Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients
Personalized Medicine, Vol. 11, Núm. 3, pp. 263-272
2013
-
Impact of pharmacogenetics on CNS side effects related to efavirenz
Pharmacogenomics, Vol. 14, Núm. 10, pp. 1167-1178
-
Pharmacogenetic analysis of SNPs in genes involved in the pharmacokinetics and response to lopinavir/ritonavir therapy
Current Drug Metabolism, Vol. 14, Núm. 7, pp. 729-737
2010
-
The genomics serving pediatrics in the investigation of the multifactorial disease
Acta Pediatrica Espanola, Vol. 68, Núm. 2, pp. 55-60